Dr. Aldape is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
University of California (San Francisco)Fellowship, Neuropathology, 1993 - 1995- University of California (San Francisco) School of MedicineInternship, Transitional Year, 1991 - 1992
- University of California San Francisco School of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1992 - 2026
TX State Medical License 2001 - 2024
WA State Medical License 2015 - 2018- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- 70 citationsMultiple craniotomies in the management of multifocal and multicentric glioblastoma: Clinical articleWael Hassaneen, Nicholas B. Levine, Dima Suki, Abhijit L. Salaskar, Alessandra de Moura Lima
Journal of Neurosurgery. 2011-03-01 - 148 citationsAssociation of an ERCC1 polymorphism with adult-onset glioma.Pengchin Chen, John K. Wiencke, Kenneth Aldape, Anna Kesler-Diaz, Rei Miike
Cancer Epidemiology, Biomarkers & Prevention. 2000-08-01 - 164 citationsNext-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagn...Rashmi Kanagal-Shamanna, Bryce P. Portier, Rajesh R. Singh, Mark J. Routbort, Kenneth D. Aldape
Modern Pathology. 2014-02-01
Journal Articles
- Heterogeneity Within the PF-EPN-B Ependymoma SubgroupAndrew Grossbach, Vijay Ramaswamy, Benjamin Lu, Mariarita Santi, Caterina Giannini, Linda M Liau, Terri S Armstrong, Sarah Leary, Matthias A Karajannis, Kenneth Aldape..., Acta Neuropathologica
Press Mentions
Pangea Biomed Begins Pilot Collaboration with the OHSU Knight Cancer Institute to Improve Cancer Therapy PrecisionOctober 24th, 2024
NCI-CONNECT and BTTC 2019 MeetingsJune 3rd, 2019
UHN Research Team Maps Genomic Landscape of Schwannoma TumoursOctober 12th, 2016- Join now to see all
Grant Support
- Prediction Of Chemoradiation Response In Glioblastoma To Individualize TherapyNational Cancer Institute2008–2011
- Cb: Pathology And Tissue Procurement CoreNational Cancer Institute2008–2011
- Towards A Refined Molecular Recursive Partitioning Analysis Model For GlioblastomNational Cancer Institute2009–2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
